DNA methylation in newborns conceived by assisted reproductive technology

Siri E. Håberg, Christian M. Page, Yunsung Lee, Haakon E. Nustad, Maria C. Magnus, Kristine L. Haftorn, Ellen Øen Carlsen, William R. P. Denault, Jon Bohlin, Astanand Jugessur, Per Magnus, Håkon K. Gjessing, Robert LyleNature Communications 2022 · DOI

TL;DR

Newborns conceived via assisted reproductive technologies (ART) show widespread differences in DNA methylation compared to naturally conceived infants, with an overall trend towards lower methylation across the genome. These epigenetic alterations are linked to genes involved in growth and neurodevelopment and persist even after accounting for parental DNA methylation and subfertility, suggesting a direct impact of ART procedures.

What Problem Does This Paper Address?

Assisted reproductive technology (ART) is increasingly used for conception, but its long-term impact on child health is not fully understood. A key question is whether observed differences in ART-conceived children are due to the procedures themselves or underlying parental factors like subfertility. Epigenetic mechanisms, particularly DNA methylation, are crucial for development and are known to undergo significant remodeling during early embryonic stages, coinciding with ART procedures. However, the extent to which ART alters the fetal epigenome and its potential health implications remained unclear, with limited and inconsistent evidence from previous studies. This paper aims to systematically investigate ART's impact on newborn DNA methylation, controlling for parental factors.

Methods

The study employed a large-scale epigenome-wide association study (EWAS) using the Illumina MethylationEPIC array to measure DNA methylation in cord blood. They compared 962 ART-conceived newborns with 983 naturally conceived newborns from the Norwegian Mother, Father and Child Cohort Study (MoBa). Key analytical steps included:

  • Quality Control: Rigorous filtering of probes and samples to ensure data integrity.
  • Statistical Modeling: Linear mixed-model regression was used to compare DNA methylation levels between ART and naturally conceived groups.
  • Covariate Adjustment: Models were adjusted for a comprehensive set of potential confounders, including maternal age, smoking, BMI, child sex, parity, plate ID, gestational age, birthweight, maternal educational level, paternal age, and cord blood cell composition.
  • Parental Factor Control: Crucially, the analysis controlled for parental DNA methylation levels and examined the role of parental subfertility (using time to pregnancy as a proxy).
  • Subgroup Analysis: Comparisons were made between different ART methods (fresh vs. frozen embryo transfer, IVF vs. ICSI).
  • Gene Annotation and Enrichment Analysis: Differentially methylated CpGs were annotated to genes, and enrichment analyses were performed for genes associated with birthweight and neurodevelopmental disorders.
  • Principal Component Analysis (PCA): PCA was used to visualize the overall patterns of DNA methylation differences in newborns and their parents.

Datasets

The study utilized data from the Norwegian Mother, Father and Child Cohort Study (MoBa). This is a large, ongoing cohort study that includes detailed questionnaires, linkage to the Medical Birth Registry of Norway, and biological samples (blood, cord blood) from mothers, fathers, and children.

  • Study Population: 983 naturally conceived newborns and 962 ART-conceived newborns, along with their parents, forming 1917 complete mother-father-child trios.
  • DNA Methylation Data: Measured using the Illumina MethylationEPIC array on cord blood samples, yielding data for 770,586 autosomal CpGs per individual.

Key Insights and Ideas

  • ART's Broad Epigenetic Footprint: The study reveals that ART procedures are associated with widespread changes in DNA methylation across the genome in newborns, not just in a few isolated locations. This suggests a systemic impact of ART on early development.
  • Global Hypomethylation Trend: While some CpGs were hypermethylated, the overall pattern observed in ART-conceived newborns was a shift towards lower DNA methylation across the genome. This global trend was not observed in the parents, hinting at a direct effect on the developing fetus.
  • Persistence of ART Effects: The observed DNA methylation differences in newborns persisted even after accounting for the DNA methylation patterns of their parents. This is a critical finding, as it helps disentangle the effects of ART from inherited parental epigenetic marks or genetic predispositions related to subfertility.
  • Link to Health-Related Genes: The differentially methylated CpGs were enriched in genes known to be involved in crucial developmental processes, including growth and neurodevelopment. This raises important questions about potential long-term health implications for ART-conceived children.
  • Differential Impact of ART Methods: While fresh embryo transfer showed a more pronounced effect on DNA methylation compared to naturally conceived infants, frozen embryo transfer also showed some differences, suggesting that the specific ART method might influence the epigenetic outcome.

Key Results

  • 607 Genome-Wide Differentially Methylated CpGs: The study identified a significant number of CpGs (at FDR < 0.01) showing differential DNA methylation between ART-conceived and naturally conceived newborns.
  • 176 Known Genes Affected: These CpGs were annotated to 176 known genes, with 55 genes having multiple significant CpGs.
  • Global Shift: Approximately 74% of CpGs showed hypomethylation, and 26% showed hypermethylation in ART-conceived newborns compared to naturally conceived ones.
  • Enrichment in Key Genes: The identified CpGs were significantly enriched for genes previously associated with birthweight and Mendelian neurodevelopmental disorders.
  • BRCA1 and HLA-DQB2 Highlighted: Two genes, BRCA1 (involved in genome maintenance and cancer susceptibility) and HLA-DQB2 (part of the immune system), had a notable number of differentially methylated CpGs.
  • Fresh vs. Frozen Transfer: Comparing fresh embryo transfer to naturally conceived newborns revealed 800 significant CpGs, more than the overall ART comparison, suggesting fresh transfer might have a stronger impact. Frozen embryo transfer showed fewer significant CpGs, but some overlap with fresh transfer findings.
  • ICSI vs. Non-ICSI: No significant differences in DNA methylation were found when comparing newborns conceived with ICSI directly to those conceived without ICSI, suggesting other ART aspects are more influential.

Limitations and Future Work

  • Limitations:
    • Correlation vs. Causation: While the study controls for many confounders, the observed associations are correlational. Direct causal links between specific ART steps and methylation changes require further investigation.
  • ART Heterogeneity: The study combined various ART procedures into an "ART" group for initial analysis, although subgroup analyses were performed. The precise impact of each specific step (e.g., media, incubation time) remains complex to dissect.
  • Data Source: Information on some covariates was derived from questionnaires, introducing potential for misclassification.
  • Timing of Methylation: The study measured methylation at birth. It's unknown if these changes persist into later childhood or adulthood.
  • Future Work:
    • Longitudinal Studies: The authors strongly emphasize the need for longitudinal assessments to determine if these early epigenetic differences persist and contribute to long-term health outcomes.
  • Gene Expression Studies: Investigating whether these DNA methylation changes correlate with altered gene expression is crucial for understanding functional consequences.
  • Mechanistic Studies: Further research is needed to elucidate the specific ART procedures or environmental factors (e.g., culture media) that drive these epigenetic alterations.
  • Clinical Implications: If future studies confirm long-term health impacts, research into targeted interventions and improvements in ART protocols would be warranted.

Summary updated

Abstract

Assisted reproductive technology (ART) may affect fetal development through epigenetic mechanisms as the timing of ART procedures coincides with the extensive epigenetic remodeling occurring between fertilization and embryo implantation. However, it is unknown to what extent ART procedures alter the fetal epigenome. Underlying parental characteristics and subfertility may also play a role. Here we identify differences in cord blood DNA methylation, measured using the Illumina EPIC platform, between 962 ART conceived and 983 naturally conceived singleton newborns. We show that ART conceived newborns display widespread differences in DNA methylation, and overall less methylation across the genome. There were 607 genome-wide differentially methylated CpGs. We find differences in 176 known genes, including genes related to growth, neurodevelopment, and other health outcomes that have been associated with ART. Both fresh and frozen embryo transfer show DNA methylation differences. Associations persist after controlling for parents' DNA methylation, and are not explained by parental subfertility.
BibTeX
@inproceedings{haberg2022dna,
  author = {Siri E. Håberg and Christian M. Page and Yunsung Lee and Haakon E. Nustad and Maria C. Magnus and Kristine L. Haftorn and Ellen Øen Carlsen and William R. P. Denault and Jon Bohlin and Astanand Jugessur and Per Magnus and Håkon K. Gjessing and Robert Lyle},
  title = {{DNA methylation in newborns conceived by assisted reproductive technology}},
  booktitle = {Nature Communications},
  year = {2022},
  doi = {10.1038/s41467-022-29540-w},
}
Figure